← /news·[MARKETS]·JUL 07·2 min read

GT Biopharma Integrates AI Across Drug Discovery and Engineering for NK Cell Engager Platform

GT Biopharma, Inc. (NASDAQ: GTBP), a clinical-stage oncology company, has integrated AI-based tools across both the discovery and engineering of its tumor-targeting NK cell engagers and mul

$Jonah Berg·NewsNTech·[MSFT]

share //

$ cat source.txt

prnewswire.com

← back to the feed Subscribe free

// related, decompiled

Tesla shares slide 11% as discount pricing squeezes profits while capex doubles on AI and robotics push

The unit economics of vehicle manufacturing leave little room for price concessions.

Owen Gallagher·2 minJUL 25

[MARKETS]02

AI spending signals send Tesla and Alphabet sharply lower

The constraint investors are now explicitly pricing is this: artificial intelligence infrastructure spending accrues upfront, at scale, and the revenue it is supposed to generate arrives later, with significant uncertain…

Marcus Cole·2 minJUL 25

[MARKETS]03

Cloud gaming's subscriber acquisition gap pushes Amazon and Microsoft toward separate models

The first-session gap has defined the ceiling for cloud gaming since the category emerged: to reach a new player, a service must clear the hardware prerequisite and the subscription decision before a single session occur…

Mara Whitfield·2 minJUL 25